Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT02736266
Brief Title: Neoadjuvant Pembrolizumab for Muscle-invasive Urothelial Bladder Carcinoma

First Submitted : April 9, 2016
First Submitted that Met QC Criteria : April 9, 2016
First Posted : April 13, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : April 9, 2019
Last Update Posted : April 11, 2019